BiopharmaTrend.com

Plexium

Plexium

Private company
PLEXIUM
San Diego

Plexium is a biotech startup focused on developing modulators of E3 ligases for the treatment of cancer, immune and neurological diseases. Plexium utilizes DELPhe platform that enables cell-based phenotypic screening of DNA-encoded libraries. Their technology miniaturizes screening to the scale of picoliter volumes.


Founded
2018
Status
Private company
Geography
United States of America based
Funding
$28 M
Patents
2

Products

No products posted yet

Services

No services posted yet


This data is part of our proprietary analytics report:

  • DNA-Encoded Library Companies
  • Protein Degraders Startups

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page